000			01835 a2200553 4500
005			20250514025714.0
264		0	_c20020412
008			200204s 0 0 eng d
022			_a1203-4754
024	7		_a10.1007/s102270000022 _2doi
040			_aNLM _beng _cNLM
100	1		_aDé Tran, Q H
245	0	0	_aTacrolimus in dermatology. _h[electronic resource]
260			_bJournal of cutaneous medicine and surgery _c
300			_a329-35 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Review
650	0	4	_aAdministration, Oral
650	0	4	_aAdministration, Topical
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aBehcet Syndrome _xdrug therapy
650	0	4	_aChild
650	0	4	_aClinical Trials as Topic
650	0	4	_aCricetinae
650	0	4	_aDermatitis, Atopic _xdrug therapy
650	0	4	_aDermatitis, Contact _xdrug therapy
650	0	4	_aDouble-Blind Method
650	0	4	_aHair _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aLupus Erythematosus, Cutaneous _xdrug therapy
650	0	4	_aMice
650	0	4	_aPlacebos
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aPyoderma Gangrenosum _xdrug therapy
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRats
650	0	4	_aSezary Syndrome _xdrug therapy
650	0	4	_aSkin Diseases _xdrug therapy
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aSkin Transplantation
650	0	4	_aTacrolimus _xadministration & dosage
650	0	4	_aTime Factors
700	1		_aGuay, E
700	1		_aChartier, S
700	1		_aTousignant, J
773	0		_tJournal of cutaneous medicine and surgery _gvol. 5 _gno. 4 _gp. 329-35
856	4	0	_uhttps://doi.org/10.1007/s102270000022 _zAvailable from publisher's website
999			_c11813376 _d11813376